Open AccessClinic and semiotics of digestive lesions with coronavirus SARS-CoV-2
Author(s) -
N. G. Kucherenko,
A. K. Ratnikova,
В. Б. Гриневич,
Е. И. Ткаченко,
Yu. A. Kravchuk
Publication year - 2021
Publication title -
èksperimentalʹnaâ i kliničeskaâ gastroènterologiâ
Language(s) - English
Resource type - Journals
ISSN - 1682-8658
DOI - 10.31146/1682-8658-ecg-186-2-20-26
Subject(s) - medicine , hydroxychloroquine , azithromycin , coronavirus , stage (stratigraphy) , intensive care medicine , convalescence , antipyretic , covid-19 , disease , pharmacology , infectious disease (medical specialty) , paleontology , analgesic , microbiology and biotechnology , biology , antibiotics
The article presents the results of the analysis of clinical features of gastroenterological manifestations of a new coronavirus infection (COVID-19) caused by the pathogen SARS-CoV-2. Taking into account the stage-by-stage system assessment of the experience of treating 1,180 patients in a multi-specialty hospital transformed into an infectious hospital, the most characteristic clinical manifestations of digestive damage by SARS-CoV-2 coronavirus are described. The article focuses on verification of changes in the digestive system, both at the stage of primary examination, and during etiotropic (in combination with hydroxychloroquine and azithromycin, interferon-alpha drugs), pathogenetic (in combination with corticosteroids, heparin drugs, according to indications - an interleukin-6 inhibitor) and symptomatic (antipyretics, antiemetics and antitussive drugs) therapy, carried out in accordance with Temporary guidelines of the Ministry of health of the Russian Federation “Prevention, diagnosis and treatment of new coronavirus infection Covid-19”. Directions for the development of algorithms for clinical and laboratory, instrumental and radiological diagnostics of changes in the digestive system in patients with COVID-19 are justified.